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Abstract
This work reports on the biocompatibility evaluation of new biodegradable starch-based polymers that are under consideration for
use in orthopaedic temporary applications and as tissue engineering sca!olds. It has been shown in previous works that by using these
polymers it is both possible to produce polymer/hydroxyapatite (HA) composites (with or without the use of coupling agents) with
mechanical properties matching those of the human bone, and to obtain 3D structures generated by solid blowing agents, that are
suitable for tissue engineering applications. This study was focused on establishing the in#uence of several additives (ceramic "llers,
blowing agents and coupling agents) and processing methods/conditions on the biocompatibility of the materials described above.
The cytotoxicity of the materials was evaluated using cell culture methods, according to ISO/EN 109935 guidelines. A cell suspension
of human osteosarcoma cells (HOS) was also seeded on a blend of corn starch with ethylene vinyl alcohol (SEVA-C) and on
SEVA-C/HA composites, in order to have a preliminary indication on cell adhesion and proliferation on the materials surface. In
general, the obtained results show that all the di!erent materials based on SEVA-C, (which are being investigated for use in several
biomedical applications), as well as all the additives (including the novel coupling agents) and di!erent processingmethods required to
obtain the di!erent properties/products, can be used without inducing a cytotoxic behaviour to the developed biomaterials.  2001
Elsevier Science Ltd. All rights reserved.
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1. Introduction
Many degradable polymeric materials, both from
natural and synthetic origin, have been investigated for
use in medical applications [1]. The increased demands
placed on biomaterials for both currently approved
and novel emerging applications continue to fuel the
interest in improving the performance of existing medi-
cal-grade polymers and for developing new polymeric
systems.
The tissue engineering approach to repair and regener-
ate damaged tissues is based on the use of sca!olds,
which act as supports for the regenerating tissue. Due to
the broad range of potential tissue engineered systems,
there is a continuous search for materials that exhibit
suitable properties, that can be tailored to several tissue
systems [2].
Apart from favourable physico-chemical and mechan-
ical properties, the most important requirement for a bio-
degradable polymer to be used in medical applications is
its biocompatibility in a speci"c environment, together
with the non-cytotoxicity of its degradation products [1].
In fact, one of the major problems in the use of synthetic
degradable polymers as biomaterials is to make sure that
they are biocompatible by themselves, and that the use of
particular additives and/or processing technologies
required to obtain di!erent properties and or con-
"gurations, will not interfere with the biocompatible
behaviour [1].
Cytotoxicity testing represents the initial phase in test-
ing biocompatibility of potential biomaterials and medi-
cal devices. Its purpose is to act as a reliable, convenient,
and reproducible screening method to detect at an early
0142-9612/01/$ - see front matter  2001 Elsevier Science Ltd. All rights reserved.
PII: S 0 1 4 2 - 9 6 1 2 ( 0 0 ) 0 0 3 7 7 - X
stage in the testing process cell death or other serious
negative e!ects on cellular functions [3}8].
Cytotoxicity deals mainly with the substances that
leach out of biomaterials. For example polymers often
have low molecular weight `leachablesa (additives, low
molecular weight components, initiator fragments, etc.)
that exhibit varying levels of physiologic activity and cell
toxicity [3,9]. Therefore, the knowledge of the degrada-
tion processes of biodegradable polymeric biomaterials
and of the e!ects that their degradation products might
have on the body is crucial for long-term success of
a biomaterial [10].
In fact, it is generally accepted that biocompatibility
means not only absence of a cytotoxic e!ect but also
positive e!ects in the sense of biofunctionality, i.e., pro-
motion of biological processes which further the intended
aim of the application of a biomaterial [11}13].
Biodegradable starch-based polymeric biomaterials
have been suggested for a wide range of biomedical
applications [14}16]. These polymers have shown to be
biodegradable. The typical products of their degradation
are lower molecular weight starch chains, fructose and
maltose. More information on the degradation mecha-
nisms relevant to these blends may be found elsewhere
[17]. Depending on the synthetic component of the
blend, processing methods, additives and reinforcement
materials used, it is possible to obtain very distinct struc-
ture/properties combinations, with several di!erent po-
tential applications, for example, as tissue engineering
sca!olds [14], as bone cements [15] or as hydrogels for
controlled release of drugs [15], and as bone substitutes
in the orthopaedic "eld [16].
This work presents a study on the in#uence of several
additives/processing methods, used to obtain several
structure/properties combinations, over the biocompat-
ible behaviour of starch-based polymers. The biocom-
patibility was evaluated on cytotoxicity trials carried out
using standardised test methods assays [18] and by
studying the cell response of osteoblastic-like cells (HOS)
to the starch-based composites.
2. Materials & methods
2.1. Processing of the starch based polymers
The polymer used in this study was a corn
starch/ethylene vinyl alcohol (60/40mol/mol) biodegrad-
able blend (SEVA-C, Novamont, Italy). The typical
amount of starch in this commercially available blend is
50}60% (wt%). The starch was obtained from corn and
has a 70/30% (wt%) amylopectin/amylose ratio. The
porous structures were obtained by injectionmoulding of
the polymer, previously mixed with a solid blowing agent
in amounts of 5, 10, 15 and 20% (wt%). The blowing
agent used is a master-batch based on carboxylic acids
(trade name Hostalon P9947 from Hoechst, Germany),
currently used in non-medical applications. This blowing




O. To produce the composite materials, the poly-
mer was reinforced with 10, 20, 30 or 40% (wt%) hy-
droxylapatite (HA, Plasma Biotal, UK), with 90% of the
particles with a medium size around 7 m (laser
granulometry). Furthermore, two di!erent coupling
agents are also being tested, for the "rst time in the
biomaterials "eld [18], in order to improve the poly-
mer/HA interface for achieving higher mechanical prop-
erties (matching the properties of human bone) and
therefore allowing for their use in orthopaedic applica-
tions. These coupling agents are: a neoalkoxy titanate
and a neoalkoxy zircanate, both obtained from Ken-
React, Bayonne, USA.
The polymer itself (without HA) was processed under
di!erent sets of conditions (temperature and back pres-
sure), aimed at isolating, respectively, the e!ects of ther-
mal and mechanical degradation during processing
of HA-"lled polymers, on the cytotoxicity of the
polymers.
All the materials were injection moulded into ASTM
dumb-bell samples of 24mm of cross section (total
length of 60mm, of which 20mm correspond to the
testing region on a tensile experiment) in a Klockner
Ferromatic FM-20. After processing, the samples were
cut into 11 cm pieces and subsequently sterilised by
ethylene oxide prior to testing.
2.2. Cytotoxicity assays
The cytotoxicity of leachables of all materials was
evaluated using cell culture methods, namely MEM ex-
traction test (72 h) * short term and long term, accord-
ing to ISO/EN 109935 guidelines [17]. UHMWPE
(Goodfellow, UK) and latex rubber (Hilversumse Rub-
berhandel, NL) were used, respectively, as negative and
positive control materials.
2.2.1. Cell culture
A cell line of mouse lung "broblasts (L929) was se-
lected for all the cytotoxicity assays. This cell line was
grown as a con#uent monolayer culture in 75 cm poly-
styrene #asks, using Dulbecco's modi"ed Eagle's medium
(DMEM, Gibco Life) supplemented with 10% foetal
bovine serum (FBS, Gibco Life), 1% Fungizone (Sigma)
and 0.5% penicillin-streptomycin (Gibco Life). Cell cul-
ture atmosphere was 5% CO

in air; 24 h before starting
each cytotoxicity test, the cells were trypsinised and cul-
tured with a density of approximately 100,000 cells/ml, in
order to establish a 80% con#uent monolayer.
2.2.2. MEM extraction test (72 h)
Extraction procedure: For all tests a constant ratio of
outer surface to #uid volume, equal to 3 cm/ml, was
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Table 1
Quantitative and qualitative scores used in the cytotoxiciy tests. The four parameters are scored (0}4) and then combined to calculate a "nal
cytotoxicity index (0}8) as described in the text
Score Con#uency Floating cells Change of cellular morphology Inhibition of cell
growth
0 100% 0% No changes during test period 0}10%
1 90}100% 0}5% Slight changes, few cells a!ected 10}30%
2 60}90% 5}10% Mild changes, some cells
round/spindle shaped
30}50%
3 30}60% 10}20% Moderate changes, many cells
round/spindle shaped
50}70%
4 0}30% '20% Severe changes, about all cells
show morphological changes
70}100%
used. In the short-term tests, the materials to test and the
control materials were extracted for 24 h at 373C and
60 rpm (in a thermostatic bath), in the complete culture
medium (the same used for cell culture).
Test culture: for the beginning of the tests, the culture
medium in each well is replaced for the same amount
(2ml) of extraction #uid. The extract of each material
(test and control) was evaluated in three-fold. The plates
were incubated at 373C and with a 5% CO

atmosphere.
Evaluation:After 24, 48 and 72 h testing, the reaction of
cells to the extracts was evaluated microscopically (in an
inverted phase contrast optical microscope connected to
a videoprinter), compared to the negative control and
scored for the con#uency of the monolayer, degree of #oat-
ing cells and changes in cellular morphology (see scores on
Table 1). At the end of the test (after 72h), the cells were
detached from the culture wells by means of trypsinization;
the percentage of growth inhibition was then determined
by cell counting, using a hemacytometer and scored after
correction for the value of the negative control.
Finally, the scores correspondent to these four quantit-
ative and qualitative parameters (see again Table 1) are
combined (the four parameters have equal weight, i.e.,
25%), resulting in a "nal cytotoxic response index
ranging from 0 to 8. The following criterion is then used







For cytotoxicity index ranging from 0 to 3, the material is
considered to pass the cytotoxicity test, for index between
3 and 5 it is advised to repeat the test and for index higher
than 5 the material is considered to fail the test.
2.2.3. MEM long-term extraction test
The long-term test was applied to evaluate the e!ects
of degradation products resulting from longer degrada-
tion periods on the cytotoxicity of the material, which
may compromise the long-term implantation of the
biomaterial.
Extraction procedure: for these tests, the materials were
extracted for di!erent periods, namely 4, 10, 20 and 40
days. It was used the same medium described for the cell
culture, but in this case the FBS was only added to the
medium before starting the test.
Test culture: as described for MEM short-term test.
Evaluation: as described for MEM short-term test.
2.2.4. MEM extraction test after artixcial ageing
Cytotoxicity tests were also carried out after an
arti"cial ageing procedure, prior to the normal 24 h ex-
traction, in order to simulate higher degradation rates.
This procedure consisted in the immersion of the test
materials in a sterile phosphate bu!er solution (PBS,
pH"7.4, Sigma) at 503C and 60 rpm for periods up to 30
days (3,15 and 30 days). After each period, the materials
were removed from the PBS and rinsed with the extrac-
tion medium before the extraction procedure. These arti-
"cial ageing tests were performed based on
a mass/volume ratio, where a gram of the test sample was
immersed in 10ml of PBS.
Extraction procedure: as described for MEM short-
term test.
Test culture: as described for MEM short-term test.
Evaluation: as described for MEM short-term test.
2.3. Direct contact tests with osteoblastic-like cells
For studying other aspects of cytotoxicity, such as the
ability of cells to adhere to the materials surface, a cell
suspension of human osteosarcoma cells (HOS) was
seeded on SEVA-C and SEVA-C composites with 10 and
30% of HA, for di!erent periods. For these experiments,
the HOS cells were cultured in MEM supplemented with
10% foetal bovine serum (FBS, Gibco Life), 1% of
non-essential amino acids (NEEA, Gibco Life), 1%
L-glutamine and 0.5% penicillin}streptomycin (Sigma).
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Fig. 1. Growth inhibition versus extraction period for SEVA-C and
SEVA-C composites.
Fig. 2. Growth inhibition observed in the extracts of SEVA-C and
SEVA-C composites after being submitted to an arti"cial ageing pro-
cedure for several di!erent periods.
The cells were seeded on the materials surface (11 cm)
and on thermanox (control material) at a density of
10,000 cells/cm, for 2, 5 and 16 h. After each one of these
periods of time, the samples were washed with warm
PBS, "xed with 1.5% glutaraldeyde (43C) for at least
30min, dehydrated to alcohol 100% and critical point
dried. Finally the samples were sputter coated with gold
and observed in a scanning electron microscope (SEM,
Philips S525), for analysing the possible attachment or
possible changes in the morphology of the HOS cells in
contact with the materials.
3. Results & discussion
All the composite materials have demonstrated a non-
cytotoxic behaviour both in the short-term and long-
term cytotoxicity testing. The same materials, which were
previously submitted to the arti"cial ageing procedure
aimed at simulating longer implantation periods, have
also passed (according to the criteria that was described
before) the cytotoxicity tests. These results are very
promising for the further application of the studied
polymers.
However, it was observed an increase in growth inhibi-
tion for longer extraction periods (see Fig. 1) and also for
longer incubation periods in PBS (see Fig. 2). Further-
more, and as it was previously reported [19], it can also
be seen that higher amounts of HA in the composite
materials produced an increased inhibitory e!ect in cells
growth. Hydroxyapatite has been widely used on its own
and as reinforcementmaterial in the biomedical "eld, and
there is no reason to believe that it could be inducing any
cytotoxic e!ect on the starch-based composites. In fact it
is well known that hydroxyapatite is biocompatible and
osteoconductive.
Therefore, these results were at "rst related to the more
severe processing conditions (higher shear stresses and
viscous dissipation during the thermal cycles) needed to
produce the composite materials, especially those with
higher HA amounts. In fact, during the processing of the
composite material, the presence of HA deeply increases
the melt viscosity, making it necessary to use slightly
higher temperatures and/or higher shear stresses in order
to allow the normal #ow of the polymer based melt.
Furthermore, the presence of the sti! "ller generates
higher levels of viscous dissipation, leading to a higher
rate of degradation of the thermal sensitive polymers that
is responsible for the obtained results.
The e!ect of the processing conditions, namely the
temperature and back pressure, on the growth inhibition
of L929 cells in contact with the extracts of these mate-
rials was studied by testing samples of the polymer itself
(without HA) processed under di!erent sets of condi-
tions. These experiments are aimed at isolating, respec-
tively, the e!ects of thermal and mechanical degradation
during processing of HA "lled polymers. The results of
these tests (displayed in Figs. 3 and 4) show that these
conditions provoke the thermal}mechanical degradation
of the materials leading to a greater concentration of
leachables in contact with the cells (possible low molecu-
lar weight chains, which are easily leached out of the
materials) and consequently to the decrease in cell prolif-
eration. Comparing results displayed in Fig. 3 and 4, it
can be easily concluded that the thermal degradation
produces a much stronger e!ect in the inhibition of cell
growth. Consequently, it might be concluded that special
care should be taken when processing these systems, that
are very sensitive to thermal degradation, as the process-
ing conditions may strongly a!ect the biomaterials
biocompatibility. This is an important conclusion that is
not easily found on published works.
In this study it was also proved that the new coupling
agents, which are very e!ective in providing a better
interface between the polymeric matrix and the
hydroxylapatite reinforcement, and thus in obtaining
better mechanical performances [18] do not induce any
toxic e!ect on L929 cells. These results are in contrast, for
instance, with typically the bad results reported for the
use of silane-based compatibilizers. Fig. 5 shows that
after 72 h in contact with the extract of the composite
material containing this coupling agent, a monolayer of
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Fig. 3. Growth inhibition vs. backpressure values used to process
SEVA-C.
Fig. 4. Growth inhibition vs. melt temperature used to process
SEVA-C.
Fig. 5. L929 cells in contact with extracts of : (a) left top: negative control; (b) left bottom: positive control; (c) right top: composite material
(SEVA-C#HA) coupled with neoalkoxy titanate; and (d) right bottom: composite coupled with neoalkoxy zircanate.
cells with normal morphology was formed. This layer
looks very similar to the cells in contact with the extract
of the negative control.
The methodology proposed to produce the porous
materials, i.e., the blowing agent used during the injection
moulding process also seems not to have any negative
e!ect in the non-cytotoxic behaviour of the starch-based
polymer, since the cells in contact with extracts of these
materials exhibit a normal morphology and prolifer-
ation, compared to the negative control. This blowing
agent is commercially available but has not been used
before to obtain biomedical products, therefore its
cytotoxicity behaviour has never been evaluated. Fur-
thermore, the faster degradation presented by these sys-
tems [14], when compared with the compact SEVA-C
mouldings, was not responsible for any observable
cytotoxicity. This manufacturing methodology, as well
as its potential for the production of tissue engineering
sca!olds, has been described in detail in previous
works [14].
Finally, direct contact experiments were performed on
starch-based polymers and composites, using osteoblas-
tic-like cells in order to evaluate the cell/materials inter-
action with respect to cell adhesion and proliferation.
The SEM analysis performed after 5 and 16 h of incuba-
tion, revealed that the response of the osteoblastic-like
cells when in contact with the composites seems to be
better than when in contact with the non-reinforced
polymer. After only 5 h of incubation it was already
possible to see some HOS cells on the surface of SEVA-C
(Fig. 6a), which formed an almost con#uent monolayer at
the end of 16 days of incubation. However, the cells on
the surface of the unreinforced material didn't seem to be
very well attached even after the longer period of incuba-
tion (16 h), when compared to the composite materials
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Fig. 6. SEM micrograph showing the HOS cells in contact with the surface of: (a) SEVA-C after 5 h incubation; (b) SEVA-C after 16h incubation;
(c) SEVA-C#10%HA after 5h incubation; (d) SEVA-C#10%HA after 16 h incubation; (e) SEVA-C#30%HA after 5h incubation; and (f ) SEVA-
C#30% HA after 16 h incubation.
and to the thermanox. In contrast, the cells seeded on the
composite materials are much #attened and better spread
on the surface (Fig. 6c}f ), and look similar to the cells
cultured on thermanox.
It was observed that cell "lapodia preferentially at-
tached to HA particles which have come out to the
surface of the composite materials, suggesting that these
particles provided sites for cell attachment and
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stimulated cell proliferation. Consequently, the com-
posites with higher amounts of HA, besides their
improved mechanical properties, seem to have a more
suitable biological behaviour, although the results from
cytotoxicity tests seemed to indicate exactly the opposite.
These results con"rm that the higher growth inhibition
obtained in the cytotoxicity tests for the materials rein-
forced with the HA, was not due to the presence of the
HA itself, but to the thermo-mechanical degradation
which results from the more severe conditions used dur-
ing the processing of the composites, that lead to the
leaching of higher amounts of low molecular weight
compounds to the culture medium.
These results also evidence that the data obtained on
cytotoxicity assays is not enough to obtain adequate
knowledge on the biocompatibility of a biomaterial. It is
necessary to test simultaneously other aspects of cell
behaviour and cell function, that deal with the appropri-
ate cell response to the presence of a biomaterials and
combine results obtained in di!erent types of assays.
Only the integrated interpretation of complementary
in vitro tests can allow for some extrapolation of what
could be the in vivo behaviour of a newly proposed
biomaterial.
4. Conclusions
The results obtained show that all the di!erent mate-
rials based on SEVA-C, which are being investigated for
use in medical applications, as well as all the additives
(including the novel coupling and blowing agents) and
processingmethods required to obtain the di!erent prop-
erties/products, can lead to a non-cytotoxic behaviour of
the biomaterials. However, special care should be taken
to avoid thermal degradation during processing, which
can lead to an inhibition of cell proliferation. In addition,
it was found that the composite materials seem to induce
a good response, with respect to adhesion and prolifer-
ation, on osteoblastic-like cells, i.e., the cells which the
implant will actually be facing in vivo, since success-
ful adhesion on arti"cial surfaces is an important pre-
requisite for inducing bone formation at the site of
implantation.
All these results are very promising for the future
application of starch-based biodegradable polymers in
the biomedical "eld, although, in order to have a fully
understanding of the biocompatibility behaviour of
starch-based polymers, it is important to further test
these materials, in particular with respect to their ability
to promote cell adhesion and proliferation and with
respect to their behaviour on in vivo experiments.
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